A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients With Metastatic Urothelial Cancer

Vascular endothelial growth factor (VEGF) is expressed in human bladder tumors. A phase II study was conducted to assess the VEGF inhibitor pazopanib in patients with metastatic, urothelial carcinoma. Nineteen patients with one prior systemic therapy were enrolled. No objective responses were observ...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Pili, Roberto, Qin, Rui, Flynn, P.J., Picus, Joel, Millward, Michael, Ho, Wing Ming, Pitot, Henry, Tan, Winston, Miles, Kiersten M., Erlichman, Charles, Vaishampayan, Ulka
Format: Artigo
Sprog:Inglês
Udgivet: 2013
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4102930/
https://ncbi.nlm.nih.gov/pubmed/23891158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2013.05.005
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker